Shell Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,706
| Closed | -$1.6M | – | 1532 |
|
|
2021
Q2 | $1.6M | Sell |
8,706
-1,108
| -11% | -$204K | 0.03% | 413 |
|
|
2021
Q1 | $1.5M | Sell |
9,814
-1,783
| -15% | -$273K | 0.03% | 415 |
|
|
2020
Q4 | $1.81M | Buy |
11,597
+3,549
| +44% | +$555K | 0.04% | 399 |
|
|
2020
Q3 | $921K | Buy |
8,048
+911
| +13% | +$104K | 0.02% | 479 |
|
|
2020
Q2 | $801K | Sell |
7,137
-10,321
| -59% | -$1.16M | 0.02% | 502 |
|
|
2020
Q1 | $1.57M | Sell |
17,458
-1,100
| -6% | -$98.8K | 0.04% | 342 |
|
|
2019
Q4 | $2.01M | Sell |
18,558
-400
| -2% | -$43.3K | 0.04% | 367 |
|
|
2019
Q3 | $1.86M | Hold |
18,958
| – | – | 0.04% | 357 |
|
|
2019
Q2 | $2.48M | Sell |
18,958
-1,136
| -6% | -$149K | 0.05% | 318 |
|
|
2019
Q1 | $2.72M | Buy |
20,094
+5,677
| +39% | +$767K | 0.06% | 305 |
|
|
2018
Q4 | $1.4M | Sell |
14,417
-1,257
| -8% | -$122K | 0.04% | 403 |
|
|
2018
Q3 | $2.18M | Sell |
15,674
-1,308
| -8% | -$182K | 0.04% | 370 |
|
|
2018
Q2 | $2.11M | Buy |
16,982
+1,769
| +12% | +$220K | 0.04% | 389 |
|
|
2018
Q1 | $1.7M | Sell |
15,213
-11,663
| -43% | -$1.3M | 0.03% | 443 |
|
|
2017
Q4 | $3.21M | Buy |
26,876
+4,336
| +19% | +$519K | 0.06% | 303 |
|
|
2017
Q3 | $3.16M | Sell |
22,540
-3,535
| -14% | -$496K | 0.07% | 286 |
|
|
2017
Q2 | $3.17M | Sell |
26,075
-1,102
| -4% | -$134K | 0.07% | 289 |
|
|
2017
Q1 | $3.3M | Sell |
27,177
-851
| -3% | -$103K | 0.07% | 279 |
|
|
2016
Q4 | $3.43M | Sell |
28,028
-6,730
| -19% | -$823K | 0.08% | 267 |
|
|
2016
Q3 | $4.26M | Buy |
+34,758
| New | +$4.26M | 0.09% | 253 |
|